Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology. (Q39410889)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 May 2013

Language	Label	Description	Also known as
English	Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.	scientific article published on 30 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Irene Bargellini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Francesco Florio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Rita Golfieri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Maurizio Grosso

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Dario Luca Lauretti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Roberto Cioni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

30 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

CardioVascular and Interventional Radiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

438-444

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Radioembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Response rates to mail surveys published in medical journals

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Is the treatment of hepatocellular carcinoma on the waiting list necessary?

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39410889&oldid=2202854599"